D
Enliven Therapeutics, Inc. ELVN
$20.63 $0.311.53% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -25.34M -28.54M -23.18M -23.16M -19.95M
Total Depreciation and Amortization 81.00K 74.00K 80.00K 80.00K 78.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 7.88M 6.84M 6.41M 5.90M 3.82M
Change in Net Operating Assets 313.00K -2.50M -510.00K 4.99M -4.38M
Cash from Operations -17.06M -24.13M -17.20M -12.19M -20.44M
Capital Expenditure -139.00K -20.00K 0.00 -22.00K -2.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -183.45M 1.45M 727.00K 14.85M -33.66M
Cash from Investing -183.59M 1.43M 727.00K 14.83M -33.67M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 218.38M 234.00K 39.97M 1.12M 1.81M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 218.38M 234.00K 39.97M 1.12M 1.81M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 17.73M -22.47M 23.50M 3.75M -52.29M